# FDA recall D-0009-2022

> **Eli Lilly & Company** · Class I · drug recall initiated 2021-09-24.

## Product

Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial; Diluent for Glucagon, 1 mL syringe. Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285; Glucagon, NDC: 0002-8031-01

## Reason for recall

SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance.  There was also a lack of full drug effect upon administration.

## Distribution

Nationwide with the USA and Puerto Rico; Canada, Argentina, Costa Rica, Mexico

## Key facts

- **Recall number:** D-0009-2022
- **Recalling firm:** Eli Lilly & Company
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-09-24
- **Report date:** 2021-10-20
- **Termination date:** 2024-09-06

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Indianapolis, IN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0009-2022

## Citation

> AI Analytics. FDA recall D-0009-2022. Retrieved 2026-06-26 from https://api.ai-analytics.org/recall/D-0009-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*